Dilip Shanghvi

Dilip Shanghvi, 69, is the Chairman and Managing Director of Sun Pharmaceutical Industries Limited (Sun Pharma), world’s 4 th largest and India’s No. 1 specialty generic pharmaceutical company. He is also the Chairman of Sun Pharma Advanced Research Company Ltd., which is engaged in R&D of new innovative drugs and delivery technologies. He was honoured with India’s fourth highest civilian award, the Padma Shri, in recognition of his distinguished contribution to the Indian Trade & Industry, in 2016. In 2018, the Indian Government appointed Mr Shanghvi to India’s central bank, Reserve Bank of India’s 21-member central board committee. He is part of the Economic Advisory Council formed by the Government of Maharashtra, India to achieve rapid and comprehensive development in the state. The Government of Gujarat, India appointed him as the Chairman of Gujarat Biotechnology University in 2022. Mr Shanghvi has been conferred with many awards and recognitions. In 2024, the Institute of Directors in India conferred the award of” Distinguished Fellowship” to Mr Shanghvi for his outstanding contribution to public service and society. In 2023, 2021 & 2020, India’s leading magazine, India Today included him in its annual Power List of 50 influential personalities in India. Some of the other awards and recognitions bestowed on him include: Moneycontrol Lifetime Achievement Award (2023), All India Management Association (AIMA) Entrepreneur of the Year (2017), NDTV Business Leader of the Year (2015), Forbes Entrepreneur for the year (2014), Economic Times’ Business Leader of the Year (2014), CNN IBN’s Indian of the Year – Business (2011), Business India’s Businessman of the Year (2011) and Ernst and Young’s World Entrepreneur of the Year (2011). He has also been awarded the Economic Times’ Entrepreneur of the Year (2008), Business Standard’s CEO of the Year (2008) and CNBC TV 18’s First Generation Entrepreneur of the Year (2007) He is a former President of the Indian Pharmaceutical Alliance (IPA) and has also served as the chairman of the Board of Governors of the Indian Institute of Technology (Bombay). He is a former trustee of the Rhodes Scholarship Program at Oxford University. In 2019, he was conferred with an honorary doctorate by the Tel Aviv University, Israel’s largest and most comprehensive institution of higher learning. Mr Shanghvi has played a vital role in the globalisation of the Indian pharmaceutical industry and continues to inspire generations of entrepreneurs in their journey to success.